Breast Cancer Subtypes Not Effectively Ruled Out By Antibody-Based Pronostic Test

by priya on  January 2, 2009 at 11:53 AM Cancer News   - G J E 4
 Breast Cancer Subtypes Not Effectively Ruled Out By Antibody-Based Pronostic Test
Dutch researchers have shown that an antibody-based test called CellSearch, which is used to detect circulating breast cancer cells in patients before and during treatment, may not detect all subtypes of breast cancer.

A research team led by Dr. Anieta Sieuwerts, of the Erasmus Medical Center in Rotterdam, The Netherlands, has identified five subtypes of breast cancer by their gene expression patterns-namely basal, HER2-positive, luminal A and B, and normal-like.

The researchers say that these subtypes vary in their natural history and response to therapy.

Studies conducted in the past suggested that women who had a decrease in circulating tumour cells after the start of treatment were likely to have a better outcome than those who did not have a decline.

However, according to the researchers, it was not known whether the CellSearch assay detected all five subtypes of cancer equally.

In the current study, Sieuwerts' team tested cells from a total of 34 cell lines that represented a mix of the five breast cancer subtypes.

The researchers found that the assay did not detect the nine normal-like breast cancer cells but did detect the other subtypes.

"New tests that include antibodies that specifically recognize normal-like breast tumor cells...are needed," the authors conclude.

The study has been reported in the Journal of National Cancer Institute.

Source: ANI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like